rpcardioRational Pharmacotherapy in CardiologyРациональная Фармакотерапия в Кардиологии1819-64462225-3653«SILICEA-POLIGRAF» LLC10.20996/1819-6446-2013-9-2-203-204rpcardio-290Research ArticleFROM THE JACCИЗ JACCEFFECT OF CHOLESTEROL BLOOD LEVEL REDUCTION BEGINNING EARLY IN LIFE ON THE RISK OF ISCHEMIC HEART DISEASEЭФФЕКТ СНИЖЕНИЯ ХОЛЕСТЕРИНЕМИИ, НАЧИНАЯ С РАННЕГО ВОЗРАСТА, НА РИСК ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦАПероваН. В.PerovaN. V.

Перова Наталья Владимировна — доктор медицинских наук, профессор, руководитель отдела изучения биохимических маркеров риска хронических неинфекционных заболеваний

Государственный научно-исследовательский центр профилактической медицины, МоскваРоссияState Research Centre for Preventive Medicine, MoscowRussian Federation20132509201592203204Copyright © Perova N.V., 20152015Перова Н.В.Perova N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpcardio.online/jour/article/view/290

Comments to the paper B.A. Ference, et al. Effect  of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease. A Mendelian Randomization Analysis (translation is published in №1 2013:90-98)

Комментарий к статье B.A. Ference et al. Влияние длительного снижения холестерина липопротеинов низкой плотности, начатого в молодом возрасте, на риск развития ишемической болезни сердца. Менделевский рандомизированный анализ (перевод опубликован в №1 2013:90-98)

ReferencesRaitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277–3.Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277–3.Cohen J, Pertsemlidis A, Kotowski IK, et al. Low LDLcholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005;37: 161–.Cohen J, Pertsemlidis A, Kotowski IK, et al. Low LDLcholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005;37: 161–.Kathiresan S. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N Engl J Med 2008;358:2299–300.Kathiresan S. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N Engl J Med 2008;358:2299–300.Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012; 60:2631–.Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012; 60:2631–.Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670–1.Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670–1.Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 2008;118:672–.Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 2008;118:672–.Avis HJ, Hutten BA, Gagne C, et al. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia. Jam Coll Cardiol 2010;55:1121–.Avis HJ, Hutten BA, Gagne C, et al. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia. Jam Coll Cardiol 2010;55:1121–.

The authors declare that there are no conflicts of interest present.